Investment to support clinical studies of Sonus Microsystem’s wearable ultrasound patch FOR IMMEDIATE RELEASE: October 23, 2025 VANCOUVER, British Columbia:   Providence Health Care Ventures  (PHCV), a strategic catalyst for health care innovation, announced today a strategic investment in Sonus Microsystems , a leader in innovative ultrasound technology, alongside angel investors including physicians in the cardiac care field. PHCV's investment marks a significant milestone

Healthcare needs imaging that behaves like a vital sign and can deliver continuous, trending, and actionable results. The goal is not just a better image at a single moment. It is better timing, earlier detection, and broader access.

Sonus Microsystems, developers of an AI-powered ultrasound wearable for autonomous on-demand ultrasound, today announced the company has entered a Collaboration Agreement with Kinetix Medicine (“Kinetix”).

You’ve entered an Emergency Room filled with people who, like you, are all seeking medical help. People are scattered around the ER, all...

Recent research, including a prospective clinical study at the PRIME Centre at BC Women’s Hospital, sheds light on the importance of the placenta in fetal development.

Ultrasound imaging will soon be taking a very sizable step forward in terms of innovative applications. Polymer-based capacitive...

In a recent interview at LSI USA (Life Science Innovation), a conference that brings together leaders and innovators from the life sciences and healthcare sectors, Hani Eskandari, CEO of Sonus Microsystems, shares insights into the company’s innovative approach to transforming ultrasound technology.  

Heart failure is a growing crisis, yet the tools to manage it, like echocardiography, remain locked inside hospitals. At Sonus, we’re making continuous, non-invasive heart monitoring possible from anywhere, using wearable ultrasound and AI. It’s time to move from reactive care to proactive, personalized intervention.